Heidelberg Pharma AG (HPHA) — Net Asset Momentum
Heidelberg Pharma AG (HPHA) recorded a net asset momentum of -37.4% as of November 2024, with net assets of €30.87 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See HPHA net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Heidelberg Pharma AG Net Asset Momentum (2016–2024)
This chart tracks Heidelberg Pharma AG's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is -37.4%, with net assets of €30.87 Million EUR as of November 2024. For live market cap and overall valuation, see HPHA market cap.
Annual Net Asset History for Heidelberg Pharma AG (2016–2024)
The table below shows the complete annual net asset history for Heidelberg Pharma AG from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check HPHA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €30.87 Million | €60.72 Million | €29.85 Million | ▼ -37.4% |
| 2023 | €49.34 Million | €70.35 Million | €21.01 Million | ▼ -26.0% |
| 2022 | €66.64 Million | €100.58 Million | €33.94 Million | ▲ +894.9% |
| 2021 | €6.70 Million | €21.73 Million | €15.03 Million | ▼ -48.0% |
| 2020 | €12.88 Million | €19.61 Million | €6.73 Million | ▼ -21.0% |
| 2019 | €16.29 Million | €22.99 Million | €6.70 Million | ▼ -37.1% |
| 2018 | €25.89 Million | €31.19 Million | €5.31 Million | ▼ -30.1% |
| 2017 | €37.02 Million | €41.49 Million | €4.47 Million | ▲ +279.5% |
| 2016 | €9.76 Million | €15.24 Million | €5.49 Million | — |